Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Where's all the monkeys that were calling S&L the "Devil"
I completely agree with the ascertain that some kind of marketing campaign is better than none.  It's puzzling that so many seem to view that as a potential pump and dump, yet they own the stock.  A marketing campaign introducing PTSC to the world would be no more harmful or risky than the divys that where paid out.  Several people enjoyed those yet didn't seem to be worried if the coffers weren't refilled.  It is basically the same risk, mgmt pays divy's assuming future licensing will occur.  A marketing campaign introduces the company and informs investors of a potential opportunity if they are willing to assume some degree of risk.  With license's already on board and a positive Markman under our wings, this stock is no more riskier than the thousands of other companies out there in much worse shape.  I don't believe it is premature to be out promoting the company.  Apparently neither does Mr. Turley, otherwise, he wouldn't be speaking at the Arch Conference.
Share
New Message
Please login to post a reply